Cortisol and inflammatory processes in ovarian cancer patients following primary treatment: Relationships with depression, fatigue, and disability
- 1 March 2013
- journal article
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 30, S126-S134
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: A meta-analysis and meta-regressionJournal of Affective Disorders, 2012
- Cancer induces inflammation and depressive-like behavior in the mouse: Modulation by social housingBrain, Behavior, and Immunity, 2011
- Diurnal cortisol dysregulation, functional disability, and depression in women with ovarian cancerCancer, 2010
- A Meta-Analysis of Cytokines in Major DepressionBiological Psychiatry, 2010
- Phase II biomarker trial of a multimarker diagnostic for ovarian cancerJournal of Cancer Research and Clinical Oncology, 2010
- Hypothalamic–pituitary–adrenal axis dysregulation in depressed children and adolescents: A meta-analysisPsychoneuroendocrinology, 2009
- Peripheral tumors induce depressive-like behaviors and cytokine production and alter hypothalamic-pituitary-adrenal axis regulationProceedings of the National Academy of Sciences, 2009
- Delayed emotional recovery after taxane‐based chemotherapyCancer, 2008
- Validation of Single-Item Linear Analog Scale Assessment of Quality of Life in Neuro-Oncology PatientsJournal of Pain and Symptom Management, 2007
- Cytokine, Sickness Behavior, and DepressionNeurologic Clinics, 2006